Artiva Biotherapeutics, Inc.·4

Nov 17, 8:39 PM ET

Raymon Heather 4

4 · Artiva Biotherapeutics, Inc. · Filed Nov 17, 2025

Insider Transaction Report

Form 4
Period: 2025-11-15
Raymon Heather
SVP, Research and Development
Transactions
  • Tax Payment

    Common Stock

    2025-11-15$3.25/sh1,375$4,46939,591 total
Footnotes (1)
  • [F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4